Equities

Tristel PLC

TSTL:LSE

Tristel PLC

Health CareHealth Care Providers
  • Price (GBX)427.50
  • Today's Change7.50 / 1.79%
  • Shares traded76.90k
  • 1 Year change15.54%
  • Beta0.4813
Data delayed at least 20 minutes, as of Feb 06 2026 16:34 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year net income at Tristel PLC changed little (from 6.49m to 6.64m) despite revenues that grew 10.80%.
Gross margin80.62%
Net profit margin14.29%
Operating margin18.07%
Return on assets14.85%
Return on equity20.31%
Return on investment17.57%
More ▼

Cash flow in GBPView more

In 2025, Tristel PLC increased its cash reserves by 40.80%, or 2.51m. The company earned 10.32m from its operations for a Cash Flow Margin of 22.20%. In addition the company used 254.00k on investing activities and also paid 7.31m in financing cash flows.
Cash flow per share0.1966
Price/Cash flow per share21.29
Book value per share0.6915
Tangible book value per share0.4821
More ▼

Balance sheet in GBPView more

Tristel PLC has a Debt to Total Capital ratio of 15.12%, a higher figure than the previous year's 14.90%.
Current ratio3.60
Quick ratio2.96
Total debt/total equity0.1781
Total debt/total capital0.1512
More ▼

Growth rates in GBP

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 5.03% and 1.95%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)2.33%
Div growth rate (5 year)18.10%
Payout ratio (TTM)40.78%
EPS growth(5 years)4.91
EPS (TTM) vs
TTM 1 year ago
2.47
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.